News & Analysis on Clinical Trial Services & Contract Research And Development
Increasing adoption of computational biology tools in today's drug discovery is the industry's attempt to compensate for shrinking product pipelines as the industry also expects to reduce the duration of the drug discovery process, especially in...
Scientists in the US have been using DNA buckyballs as a nanoscale building material, constructing geometric shapes and even working mechanical devices with the hope of developing this technology for drug delivery, using synthetic DNA as building blocks.
Drug delivery specialists, Inyx has announced the acquisition of Celltech Manufacturing Services from biopharmaceutical company UCB for €27.5 million (€22.3 million). The acquisition adds to Inyx's recently established operating base in the US.
The first (14) Carbon microdosing study to take place in the United States has been completed by Radiant Research, who believe this approach to clinical trials will lead to more accurate and earlier human pharmacokinetic (PK) data on drug candidates...
In its second set of financial results, Superfos has reported earnings in the first six months of 2005 that have been affected by high prices of raw material. The Danish packaging firm appear to have resolved its delivery problems that plagued it last...
A harmless virus could hold the key to the production of a more effective HIV drug after researchers employed this virus in ongoing studies. The research aims to outmanoeuvre the mutating nature of the HIV virus, which has become skillful at...